| 注册
首页|期刊导航|世界中医药|基于骨免疫学论中医药抑制类风湿关节炎骨破坏的研究进展

基于骨免疫学论中医药抑制类风湿关节炎骨破坏的研究进展

夏璇 陈杰君 张磊 王茂杰 黄闰月 储永良

世界中医药2024,Vol.19Issue(15):2352-2356,5.
世界中医药2024,Vol.19Issue(15):2352-2356,5.DOI:10.3969/j.issn.1673-7202.2024.15.024

基于骨免疫学论中医药抑制类风湿关节炎骨破坏的研究进展

Traditional Chinese Medicine in Inhibiting Bone Destruction in Rheumatoid Arthritis Based on Bone Immunology Theory:A Review

夏璇 1陈杰君 1张磊 2王茂杰 1黄闰月 1储永良2

作者信息

  • 1. 广州中医药大学第二附属医院/广东省中医院,广州,510120
  • 2. 广州中医药大学第二附属医院/广东省中医院,广州,510120||广东省中医院珠海医院,珠海,519015
  • 折叠

摘要

Abstract

Rheumatoid arthritis(RA)is an autoimmune disease characterized by synovitis,cartilage,and bone destruction,with a high rate of disability.The immune and inflammatory responses in RA interact with bone cell metabolism,with a key mechanism in-volving the imbalance in the receptor activator of nuclear factor-κB ligand(RANKL)/RANK/osteoprotegerin(OPG)signaling path-way.This imbalance leads to decreased osteoblasts and increased osteoclast apoptosis and abnormal activation.While western medi-cine primarily focuses on inhibiting inflammatory responses and related cytokine secretion to slow disease progression,long-term use is associated with notable adverse effects.Research into traditional Chinese medicine(TCM)for preventing and treating bone de-struction in RA has advanced,but both basic and clinical research still face certain limitations.

关键词

骨免疫学/中医药/类风湿关节炎/骨破坏/炎症反应/核因子κB受体活化因子/核因子κB受体活化因子配体/骨保护素

Key words

Bone immunology/Traditional Chinese medicine/Rheumatoid arthritis/Bone destruction/Inflammatory responses/Receptor activator of nuclear factor kappa-B/Receptor activator of nuclear factor kappa-B ligand/Osteoprotegerin

分类

医药卫生

引用本文复制引用

夏璇,陈杰君,张磊,王茂杰,黄闰月,储永良..基于骨免疫学论中医药抑制类风湿关节炎骨破坏的研究进展[J].世界中医药,2024,19(15):2352-2356,5.

基金项目

国家自然科学基金面上项目(82274421) (82274421)

广东省中医院中医药科学技术研究专项(YN2020QN16) (YN2020QN16)

世界中医药

OA北大核心CHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文